Lissa Nazal

Lissa Nazal is an experienced clinical and research professional with a strong background in pharmaceuticals and therapeutics. Currently serving as the Director at Elevar Therapeutics since April 2022, Lissa previously held roles as Director at Rain Therapeutics and Associate Director at Revance Therapeutics, Inc. Other significant positions include Clinical Program Manager in Hematology at Astex Pharmaceuticals, Global Lead Study Manager in Oncology at Astellas Pharma, and Global Clinical Trial Manager in Neuroscience at Takeda. Lissa's earlier experience includes various roles in clinical research, including Senior Clinical Research Associate at PharmaNet and Clinical Research Associate II at Kendle International, as well as a Research Assistant/Study Coordinator at Children's Memorial Hospital.